EP2023908A1 - Timbre médical multicouches comprenant un centre imperméable - Google Patents

Timbre médical multicouches comprenant un centre imperméable

Info

Publication number
EP2023908A1
EP2023908A1 EP07752632A EP07752632A EP2023908A1 EP 2023908 A1 EP2023908 A1 EP 2023908A1 EP 07752632 A EP07752632 A EP 07752632A EP 07752632 A EP07752632 A EP 07752632A EP 2023908 A1 EP2023908 A1 EP 2023908A1
Authority
EP
European Patent Office
Prior art keywords
muco
patch
base
contact side
sheet
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07752632A
Other languages
German (de)
English (en)
Inventor
Jeffrey T. Haley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oramelts International Inc
Original Assignee
Oramelts International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oramelts International Inc filed Critical Oramelts International Inc
Publication of EP2023908A1 publication Critical patent/EP2023908A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Definitions

  • drugs that cannot be delivered to the blood via the stomach because acids and enzymes of the stomach will destroy them.
  • examples of such drugs include protein drugs, drugs made with peptide molecular groups, and vaccines. These drugs must be delivered by injection or by absorption through mucous membranes, such as mucous membranes of the mouth, nose, or vagina.
  • mucous membranes such as mucous membranes of the mouth, nose, or vagina.
  • the first muco-adhesive oral patch was made by pressing grains into a thin, wide tablet.
  • the tablet can be made to adhere on only one side by first pressing into a tablet die a small amount of powder and then adding more powder of a different composition and pressing again.
  • Canker Cover sold by Quantum, is an example.
  • Orajel Protective Mouth Sore Discs
  • a thin edge is inconsistent with multiple layers.
  • Pressing grains into a tablet can never make a patch that is flexible and yet strong enough not to fall apart because there are no fibers or polymer strands that cross grain boundaries. If the grains become elastic enough to flex, due to heat or moisture, the grains will pull apart from each other.
  • Pressing grains into a tablet also can not produce a thin, tapered edge.
  • the thickness of the edge must be determined by achieving the proper pressure, not by the final thickness dimension, which requires that the edge thickness vary according to the exact amount and composition of the powders put into the press for each tablet.
  • the Orajel patch was produced with the thinnest edge practical by tablet pressing, about .75 mm, which is about 30 thousandths of an inch. To press a tablet with two layers requires a cliff edge at least twice this thick.
  • the only solution to the problem of strength with flexibility described above is to mix the preferred ingredients together in a liquid and then cure it to a solid.
  • the mixture will include long polymer molecules, some of which may be organized into fibers.
  • the curing may be accomplished by cooling or by evaporating a solvent or both.
  • the preferred ingredients are mixed together and heated to a liquid, then formed to a sheet, and then cooled. Because long chain molecules can be intertwined with no grain boundaries, it is strong yet can be flexible.
  • the sheets can be formed by pouring onto a flat table, like making glass, or can be rolled or extruded. Layers can be separately formed and then bonded together or can be co-extruded.
  • the sheet is then die cut into patches of the preferred shape.
  • the die-cut sheet method can not produce a thin, tapered edge.
  • the edges of the patch cut by the die are vertical "cliff' edges. Nor can it produce a lenticular shape. Both sides are flat.
  • the invention is a muco-adhesive patch for delivery of drugs into mucous membranes wherein muco-adhesive material is formed into a planer base with a non-adhesive layer adhered to a non-muco-contact side of the base and covering the entire non-muco-contact side.
  • a water impermeable layer covers the center of the patch and less than half of the muco-contact side of the patch.
  • Drugs may be added to this patch for delivery into mucous membranes by mixing the drug with an adhesive material (if it is not sufficiently adhesive by itself) and placing a spot of the drug (plus adhesive) onto the exposed side of the water impermeable layer.
  • a person who wishes to take the drug places the patch in the mouth with the drug against the mucous membrane of the buccal (cheek), with the non- adhesive side of the patch contacting the teeth or gums opposite the buccal.
  • the ring of the muco-contact side of the base that is not covered with a water impermeable layer adheres to the mucous of the buccal and prevents saliva from passing between this portion of the base and the buccal, thereby isolating the drug from saliva flow. Because the drug cannot pass through the water impermeable layer, it can only migrate into the mucous membrane of the buccal.
  • the patch When a muco-adhesive patch adheres to a mucous membrane, the patch must absorb water from the membrane to prevent a layer of water from accumulating between them and interfering with adhesion. This causes a net flow of water through the surface of the membrane into the patch. This flow significantly impedes migration of molecules in the opposite direction, from the patch into the membrane.
  • the water impermeable layer in the center of the adherent side of the patch blocks flow of water through this area, allowing the drug to migrate into the membrane.
  • a portion of the drug which enters the mucous membrane will travel laterally in the mucous membrane beyond the edge of the impermeable layer and then either flow into the saliva in the mouth or be absorbed by the non-coated portion of the patch. For this reason, it is preferred to place the drug in a relatively small spot at the center of a relatively larger impermeable layer to minimize the amount of drug that travels through the membrane around the end of the impermeable layer and into the patch or the saliva.
  • the present method and device are suitable for use with volatile drugs and excipients, as no heat treatment step is involved or necessary.
  • the present invention is useful with drugs such as nicotine, nitroglycerin, amyl nitrate, and scopolamine.
  • the present device is also useful with drugs such as fentanyl, which will typically be incorporated into the patch using nonaqueous, volatile vehicles and/or enhancers which, because they volatilize during heat treatment, have proven difficult to incorporate into a transdermal delivery device by conventional means.
  • a percutaneous absorption enhancer will be present in the device along with the drug, i.e., will be initially deposited on the impermeable layer together with the drug.
  • Any of the many percutaneous absorption enhancers known in the art may be used in conjunction with the present invention. For examples of suitable enhancers, see U.S. Pat. Nos.
  • Such a medical patch can be made with multiple layers by passing a single sheet such as a sheet of plastic through a production line in which each layer is applied in turn maintaining registration by reference to edges of the sheet or to marks on the sheet. Each layer as applied need be no larger than necessary so no trimming is required, and the sheet can be used as packaging material.
  • Figure 1 shows a side view of a patch made according to the present invention.
  • Figure 2 shows the muco-contact side of a patch made according to the present invention.
  • Figure 1 shows, in side view, an embodiment of the patch 1 comprising a planer base having a muco-contact side 3 and a non-muco-contact side 2.
  • the non-muco-contact side 2 is entirely covered with a layer that presents it from being adhesive to any of mucous membranes, gums, teeth, or orthodontic devices, such as any hydrophobic material such as a lipid.
  • Figure 2 shows the muco-contact side of the patch.
  • An outer ring 8 of the muco-contact side is not covered with an impermeable membrane, leaving exposed the muco-adhesive material of the patch.
  • a central portion of the muco- contact side is covered with an impermeable layer 7 which blocks passage of water and large molecules, including drug molecules. Drug molecules (plus binder molecules if needed) are adhered in a spot 6 in the center of the impermeable layer 7 on the muco-contact side of the patch.
  • the planer base may be made by extruding plainer material and then cutting to a desired shape or by pressing powders into a tablet of the desired shape or by depositing a blob of viscous liquid and then curing the deposited blob to a solid.
  • One way of making the patch is taught in US patent application no. 11/157,054 which is incorporated by reference.
  • One method for coating a side of the patch to make it non-adhesive is to spray on a layer of liquid hydroxy-propyl-ethyl-cellulose (HPEC) or hydroxy-propyl- methyl-cellulose (HPMC) or shellac, and then evaporating away a solvent which carries the liquid coating material.
  • HPEC liquid hydroxy-propyl-ethyl-cellulose
  • HPMC hydroxy-propyl- methyl-cellulose
  • shellac evaporating away a solvent which carries the liquid coating material.
  • suitable GRAS-certified materials include but are not limited to monoglycerides, triglycerides, waxes such as paraffin, fatty acids, fatty alcohols and mixtures thereof.
  • Sorbitan monostearate (SPAN 60) with hydroxypropyl cellulose (HPC LF) is suitable If the base is made by pressing powders in a tablet press, a non-adhesive layer may be made by prior art techniques for making a two layer tablet. First, a thin tablet is made by pressing powders into a female die and lower with a male upper punch, then the male punch is removed, additional powders are added for the second layer, and the male punch is inserted once again. Either layer can be formed first. An oral patch called Canker Cover sold by Quantum, Inc. of Eugene Oregon is made by this method.
  • the non-adhesive layer can be extruded onto the base or co-extruded along with the base.
  • a patch made this way called BEMA is marketed by Bio Delivery Sciences International of Texas.
  • the spot of impermeable material can be added to the base by any printing method such as silk screen printing, Gravure-type printing, or extrusion coating. Once the impermeable layer has cured, a smaller spot of drug plus adhesive molecules can be added, again by any printing process such as silk screen printing.
  • the base is made by depositing a blob of viscous liquid and then curing to a solid, the preferred method implements the following steps. First, a small spot of drug plus adhesive is printed in many spots on a sheet of plastic.
  • the impermeable layer is printed on top of these spots.
  • this layer is sufficiently cured, such as by evaporation or gelation, the viscous liquid is deposited onto each of the spots.
  • a non-adhesive coating is sprayed onto each base and the coating is cured.
  • the patches are still adhered to the original layer of plastic. They are then encased with a layer of film, such as aluminum foil, that is sealed to the plastic around the circumference of each patch and the entire assemblage is die cut to a final product.
  • a suitable binder for holding the drug to the plastic is HPMC, which is water soluble.
  • Suitable materials for the impermeable layer are HPEC or shellac, which are not water soluble.
  • Suitable materials for the base include the hydrophilic gums, the more hydrophilic the better for maintaining adhesion until the drug has been fully absorbed into the mucous membrane. These materials include xanthan gum, konjac gum, guar gum, carrageen, agar, gelatin, pectin, cellulose, starch, maltodextrin or other polysaccharides, diblock copolypeptide amphiphiles, carboxymethylcellulose, hydroxymethylcellulose, polyacrylic acid, and carbopol- 934. To maintain flexibility, a plasticizer, such as glycerol, may be included.
  • Suitable material for the non-adhesive layer is HPEC or shellac with a plasticizer to make it flexible enough to avoid cracking as the patch flexes.
  • the first method is to mix the preferred ingredients into a liquid with a solvent, deposit blobs of the liquid onto a sheet or into shallow, dished molds, and then dry out the solvent, causing the blobs to thin into the perfect shape, thickest at the center and tapering to a thin edge.
  • This is the method by which Oramelts Corporation manufactures Cankermelts.
  • This method is highly economical because the sheet is used as a part of the final packaging and, after drying, a foil lid is heat sealed over the patches.
  • Use of the solvent requires only modest temperatures that present no complications for manufacturing, and water can be used as the solvent to minimize cost and problems for workers.
  • the second method is to liquify the preferred ingredients with heat, inject the liquid into molds, and then cure by cooling. This is the same process as for making injection molded thermoplastic parts.
  • a plastic sheet liner can be put into one side of the mold so that the patch remains adhered to the liner when it is demolded. The plastic sheet then becomes a part of the final packaging.
  • the third method is to start with a sheet, like the prior art die-cut method, and then apply a hot press that melts and deforms the sheet material to produce a thin, tapered edge and a raised center.
  • a hot press that melts and deforms the sheet material to produce a thin, tapered edge and a raised center.
  • all the material in a sheet can be forced into the body of one of the patches, which may be close-packed rectangles with rounded corners or hexagonally-close-packed circles, leaving no waste trimmings between patches.
  • the heat and pressure can be applied through a layer of flexible packaging material on each side of the patch so that the patches need not touch the hot press surfaces to minimize contamination risk.
  • a thin layer of different material on one side of the patch or the other, such as to block drug release or eliminate adhesiveness or stop water migration on one side or provide a burst drug release on one side. This can be done by three methods.
  • Spraying Spraying a coating on one side of the patch or spraying a spot of coating on the plastic sheet before the patch body is deposited allows a coating to be placed on either side of the patch. A small nozzle sprays a circle of preferred diameter at the right spot. These methods work better than spraying on tablets or extruded sheets of patch material because the plastic sheet maintains registration for all steps in the process and no sprayed material is wasted by over spray or by spraying base material that is trimmed off.
  • Granular materials that can not be sprayed can be suspended in a high viscosity gel, such as benzocaine crystals suspended in xanthan gum in water, and deposited as a blob of preferred diameter on the plastic sheet. The blob is then dried before the patch body is deposited. Because the blob is mostly water, it will dry to a thin layer. Like with spraying, the plastic sheet maintains the registration. 3. Printing: To place a spot of material on one side of the patch with a sharply defined edge, printing heads can be placed over the production line on which the plastic sheet moves.
  • a high viscosity gel such as benzocaine crystals suspended in xanthan gum in water
  • the head openings can be selected to deposit a liquid in a layer of uniform thickness of a preferred diameter at the preferred spot on the plastic sheet, either as a first layer or as a second layer on top of a previously sprayed or printed layer.
  • the preferred printing method is screen printing, but flexo and gravure printing can also be used.

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Ink Jet (AREA)

Abstract

L'invention porte sur un timbre mucoadhésif permettant de distribuer des médicaments aux membranes muqueuses. Du côté du timbre en contact avec la muqueuse, une couche imperméable à l'eau recouvre le centre du timbre et moins de la moitié du côté du timbre en contact avec la muqueuse. On peut ajouter des médicaments en mélangeant le médicament à une matière adhésive et en plaçant un point de médicament mélangé à l'adhésif sur le côté exposé de la couche imperméable à l'eau. On peut fabriquer un timbre médical lenticulaire à bord mince biseauté comprenant de multiples couches en faisant passer une feuille simple telle qu'une feuille de plastique à travers une ligne de production dans laquelle chaque couche est appliquée, leur alignement étant conservé par référence aux bords de la feuille ou à des marques sur la feuille.
EP07752632A 2006-03-07 2007-03-07 Timbre médical multicouches comprenant un centre imperméable Withdrawn EP2023908A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78000906P 2006-03-07 2006-03-07
US79563706P 2006-04-26 2006-04-26
PCT/US2007/005947 WO2007103511A1 (fr) 2006-03-07 2007-03-07 Timbre médical multicouches comprenant un centre imperméable

Publications (1)

Publication Number Publication Date
EP2023908A1 true EP2023908A1 (fr) 2009-02-18

Family

ID=38475193

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07752632A Withdrawn EP2023908A1 (fr) 2006-03-07 2007-03-07 Timbre médical multicouches comprenant un centre imperméable

Country Status (3)

Country Link
EP (1) EP2023908A1 (fr)
JP (1) JP2009528900A (fr)
WO (1) WO2007103511A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101264843B1 (ko) * 2008-12-31 2013-05-16 주식회사 삼양바이오팜 휘발성 약물 또는 열에 약한 약물의 경피 투여용 패치 제조방법 및 그 경피 패치
JP5806701B2 (ja) * 2013-05-07 2015-11-10 日本写真印刷株式会社 経皮投与用貼付剤の製造方法及び経皮投与用貼付剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991006290A1 (fr) * 1989-11-03 1991-05-16 Riker Laboratories, Inc. Composition bioadhesive et patch
EP1117390B1 (fr) * 1998-10-02 2004-08-18 3M Innovative Properties Company Systemes d'administration de medicaments directement sur les muqueuses
KR100302572B1 (ko) * 1998-11-10 2002-03-21 허계성 필름형구강점막부착제제및그의제조방법
KR20030054221A (ko) * 2001-12-24 2003-07-02 애경산업(주) 구강용 적층 필름 조성물 및 그 제조방법
JP5137286B2 (ja) * 2003-06-10 2013-02-06 帝國製薬株式会社 フェンタニル含有口腔粘膜貼付剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2007103511A1 *

Also Published As

Publication number Publication date
WO2007103511B1 (fr) 2008-02-28
WO2007103511A1 (fr) 2007-09-13
JP2009528900A (ja) 2009-08-13

Similar Documents

Publication Publication Date Title
JP6557270B2 (ja) 可変断面特性を有する生体適合性フィルム
EP0400078B1 (fr) Dispositif de distribution transcutanee de medicament implante
KR100514306B1 (ko) 부프레노르핀 또는 약리학적으로 이와 동등한 물질을 구강에 사용하고 방출시키기 위한 편평한 약제와, 그 제조 방법
US20090110717A1 (en) Transmucosal composition
MXPA02005857A (es) Preparacion medicamentosa plana para la administracion transmucosa de oxicodona o un principio activo similar en la cavidad bucal, para su aplicacion en el tratamiento contra dolor y la adiccion.
WO2003086345A1 (fr) Procede de chargement d'un dispositif d'administration de medicaments
CN1747656A (zh) 速溶剂型的包装和分配
EP1339397A2 (fr) Couche de recouvrement ou couche protectrice pelable comportant des absorbants et des agents de formation de canaux, pour un systeme therapeutique transdermique
EP2133060A1 (fr) Procédé pour produire une préparation pour une administration par voie orale
HU206992B (en) Method for producing transdermal system advantageously plaster suitable for controlled feeding active ingredient
EP0656771A1 (fr) Dispositif d'apport medicamenteux percutane depose par empreinte
US8349120B2 (en) Multi-layer patch made on a sheet and enclosed in a blister
US20070243238A1 (en) Treating mouth sores with patches adhered to teeth
JP2007520517A (ja) 口腔内で使用するための平型システム
NZ207796A (en) Adhesive layered product for controlled release of active ingredients to skin
US20100074944A1 (en) Transdermal Tobacco Alkaloid Reservoir Patch
EP2023908A1 (fr) Timbre médical multicouches comprenant un centre imperméable
US20090169606A1 (en) Low Flexural Strength Transdermal Tobacco Alkaloid Patch
US20090246264A1 (en) Transdermal Tobacco Alkaloid Patch
US20070098648A1 (en) Treating mouth sores caused by dental braces with blobs of hydrophilic gums
RU2762081C1 (ru) Многослойная пероральная тонкая пленка
NZ240096A (en) Fragrance releasing device

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081007

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1128244

Country of ref document: HK

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20110221

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1128244

Country of ref document: HK